Sinupret Forte
Natural health product licensed in Canada
- Licence holder
- Bionorica SE
- NPN or DIN-HM
- 80030340
- Status
- Active licence
- Licence date
- 9 March 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Oxyde de magnésium, Carbonate de calcium, Carbonate de sodium anhydre, Jaune de quinoléine (E104), Maize starch, Sucrose, Fécule de pommes de terre, Glucose, Liquid, Dextrine, Butyl methacrylate, Carmin d'indigo, Talc, Sorbitol, Shellac, Silica colloidal anhydrous, Lactose, Quinoline yellow (E 104) aluminium lake, Castor oil, Acide stéarique, Povidone, Gélatine, Dioxyde de titanium, Laque d'aluminium-carmin d'indigo, Wax, Montan glycol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | maximum: 1 Comprimé | maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides symptomatic relief of nasal congestion and headaches in those suffering from sinusitis when taken in combination with conventional antimicrobial and decongestant therapy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80030340
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.